[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
March 1, 2006

Attempts to Recruit Stem Cells for Repair of Acute Myocardial InfarctionA Dose of Reality

Author Affiliations
 

Author Affiliations: Heart Institute, Good Samaritan Hospital and Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, Los Angeles.

JAMA. 2006;295(9):1058-1060. doi:10.1001/jama.295.9.1058

Experimental studies suggest that most of the myocardial cells destined to die following an acute coronary artery occlusion will do so within 3 to 6 hours.1 Early coronary reperfusion with thrombolytic therapy, angioplasty, and/or stenting can certainly salvage ischemic myocardium and improve clinical outcome but late reperfusion will not salvage myocardium. However, there are therapies for which strong evidence has demonstrated benefit even when started beyond 24 hours. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers reduce the risk of heart failure and premature death, presumably by decreasing progressive left ventricular dilatation and remodeling.2,3 Other established and effective adjunctive therapies include antiplatelet agents and statins.4

First Page Preview View Large
First page PDF preview
First page PDF preview
×